Drugs / DC-DELAY
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07163403 | Sep 2025 → Sep 2028 expected | Lynch syndrome | Fundacion Clinic per a la Recerca Biomédica | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DC-DELAY | “Autologous peripheral blood differentiated and matured adult dendritic cells loaded with Frameshift-derived neopeptides (FSDN) (DC-DELAY).” NCT07163403 ↗ |
| Modality | Cell therapy | “Autologous peripheral blood differentiated and matured adult dendritic cells loaded with Frameshift-derived neopeptides (FSDN) (DC-DELAY).” NCT07163403 ↗ |